We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ARUP, Labceutics Partner
News

ARUP, Labceutics Partner

ARUP, Labceutics Partner
News

ARUP, Labceutics Partner

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ARUP, Labceutics Partner "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

According to the partners, up to 70 percent of pharma pipelines use companion or complementary diagnostics. Under the collaboration, ARUP and Labceutics will provide pharma companies services that allow them to efficiently incorporate such tests in their drug development and commercialization efforts through lab networks.

ARUP provides test development and validation services to pharmaceutical partners through a program called PharmaDx, and is working with a number of drug firms in this regard in a variety of disease areas, including oncology and infectious diseases. According to the firm, its services reach more than 20 percent of US hospital labs.

Labceutics, a division of the personalized medicine-focused consulting firm Diaceutics, provides lab implementation services to pharma. The firm will help drug companies create lab networks to perform companion and complementary tests that are important for the delivery of their drugs, and then work with labs to ensure they are performing the tests efficiently and according to quality standards.

"With our Labceutics partnership, we will be providing specific solutions for the pharmaceutical industry with novel tests that support targeted therapy launches and ongoing clinical testing," Sherrie Perkins, senior VP of R&D at ARUP, said in a statement.

Advertisement